drugset / Trial / NCT00539201

GSK706769 A First Time in Human Study For Males and Females

NCT00539201

Phase 1 Terminated 34 enrolled GlaxoSmithKline
RandomizedSingle-groupDouble-blindTreatment

Summary

To determine safety, tolerability and pharmacokinetics of GSK706769

Timeline

Start
2007-09
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK706769 Unknown

Indications

No indication recorded.